[Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders].

Alina Lozinski*, Sharon Baum, Lior Sagi, Alex Volkov, Henri Trau, Aviv Barzilai

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of '[Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders].'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science